ERBB2 and breast cancer: As in the case of ER-positive BCs, connections among autophagy and HER-2 receptor down-stream signaling have been detected and targeted therapies deactivating HER-2 signaling seem to induce autophagy [73].Chemotherapeutic drugs are largely employed in BC treatment, especially in TNBC where the lack of proper receptors does not allow for targeted therapy.